In the past several weeks over 110,000 diabetes advocates signed onto a petition asking the FDA to issue draft guidance by December 1 that would advance the testing and development of artificial pancreas systems. We wanted to share the news that FDA has just published this important draft guidance and based on an initial review JDRF is encouraged that it appears to lay a foundation for accelerating the development and availability of artificial pancreas technologies.  Read more in this JDRF statement just released.

What’s Next?

• In the coming weeks, our scientific and regulatory experts will review the draft guidance in detail and provide comments to FDA.
• We will be back in touch with you about additional steps you can take! 
  

Continue to follow along and update your family and friends by sharing this post on Facebook or Twitter (use hashtag #AP100k).

Talk to you next week,

Hasan